|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Auran Mitch C/O 821 FOX LANE SAN JOSE, CA 95131 |
Vice President |
/s/ Carolyn M. Bruguera, Attorney-in-Fact for Mitch Auran | 12/04/2006 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Determined by using the average closing price per share of MEND for the twenty trading day period ending on November 27, 2006 |
(2) | All of these securities are held by VasCon LLC and include all of the shares of Micrus Endovascular Corporation acquired on November 30, 2006 in connection with an asset purchase transaction between Micrus Endovascular Corporation, its wholly-owned subsidiary, Micrus Design Technology, Inc., VasCon, LLC, and the members of VasCon. The reporting person is a member of VasCon LLC and disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest in the securities resulting from his proportionate interest in the securities as a member of VasCon LLC. This report shall not be deemed an admission that the reporting person is the beneficial owner of any such securities for which he has disclaimed beneficial ownership for purposes of Section 16 or for any other purpose. |